MRM2 variants in families with complex dystonic syndromes: evidence for phenotypic heterogeneity

J Med Genet. 2023 Apr;60(4):352-358. doi: 10.1136/jmg-2022-108521. Epub 2022 Aug 24.

Abstract

Background: Dystonia involves repetitive movements and muscle contractions leading to abnormal postures. We investigated patients in two families, DYAF11 and M, exhibiting dystonic or involuntary movement disorders.

Methods: Clinical investigations were performed for all patients. Genetic analyses included genome-wide linkage analysis and exome sequencing followed by Sanger sequencing validation. MRM2-specific transcripts were analysed from participants' blood samples in Family DYAF11 after cloning of gene-specific cDNA.

Results: Four affected siblings in Family DYAF11 had progressive dystonic features. Two patients in Family M exhibited a neurodevelopmental disorder accompanied by involuntary movements. In Family DYAF11, linkage was detected to the telomere at chromosome 7p22.3, spanning <2 Mb. Exome sequencing identified a donor splice-site variant, c.8+1G>T in MRM2, which segregated with the phenotype, corresponding to the linkage data since all affected individuals were homozygous while the obligate unaffected carriers were heterozygous for the variant. In the MRM2 c.8+1G>T allele, an aberrant alternative acceptor splice-site located within exon 2 was used in a subset of the transcripts, creating a frameshift in the open reading frame. Exome sequencing in Family M revealed a rare missense variant c.242C>T, p.(Ala81Val), which affected a conserved amino acid.

Conclusions: Our results expand the clinical and allelic spectrum of MRM2 variants. Previously, these descriptions were based on observations in a single patient, diagnosed with mitochondrial DNA depletion syndrome 17, in whom movement disorder was accompanied by recurrent strokes and epilepsy. We also demonstrate a subset of correctly spliced tt-ag MRM2 transcripts, raising the possibility to develop treatment by understanding the disease mechanism.

Keywords: gene expression profiling; germ-line mutation; high-throughput nucleotide sequencing; human genetics; movement disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exons
  • Frameshift Mutation*
  • Humans
  • Mutation
  • Pedigree
  • Phenotype
  • RNA Splice Sites*
  • Syndrome

Substances

  • RNA Splice Sites